364 related items for PubMed ID: 4004483
1. [Value of the assay of plasma steroids in the control of congenital adrenal hyperplasia].
Theintz GE, Sizonenko PC.
Arch Fr Pediatr; 1985 Mar; 42(3):211-7. PubMed ID: 4004483
[Abstract] [Full Text] [Related]
2. Response to treatment of congenital adrenal hyperplasia in infancy.
Young MC, Hughes IA.
Arch Dis Child; 1990 Apr; 65(4):441-4. PubMed ID: 2346339
[Abstract] [Full Text] [Related]
3. [Use of steroid indicators in monitoring the treatment of congenital adrenal hyperplasia].
Sulcová J, Lisá L, Dvorák P, Hampl R, Stárka L.
Cesk Pediatr; 1990 Jun; 45(6):353-6. PubMed ID: 2289256
[Abstract] [Full Text] [Related]
4. Plasma levels of androgens and 17 alpha-OH-progesterone as an index of the adequacy of treatment in congenital adrenal hyperplasia.
Ilondo MM, Vanderschueren-Lodeweyckx M, Pizarro M, Vlietinck R, Malvaux P, Eggermont E, Eeckels R.
Horm Res; 1983 Jun; 18(4):175-85. PubMed ID: 6227545
[Abstract] [Full Text] [Related]
5. [17-hydroxyprogesterone, testosterone and androstenedione in treated congenital adrenogenital syndrome].
von Schnakenburg K, Bidingmaier F, Knorr D.
Monatsschr Kinderheilkd (1902); 1977 May; 125(5):579-80. PubMed ID: 876244
[No Abstract] [Full Text] [Related]
6. [Salivary 17-hydroxyprogesterone concentration in monitoring of the treatment of congenital adrenal hyperplasia].
Arisaka O, Shimura N, Nakayama Y, Arisaka M, Yabuta K.
Dtsch Med Wochenschr; 1988 Dec 09; 113(49):1913-5. PubMed ID: 3197614
[Abstract] [Full Text] [Related]
7. Randomised controlled trial of growth effect of hydrocortisone in congenital adrenal hyperplasia.
Silva IN, Kater CE, Cunha CF, Viana MB.
Arch Dis Child; 1997 Sep 09; 77(3):214-8. PubMed ID: 9370898
[Abstract] [Full Text] [Related]
8. Plasma progesterone, 17-hydroxyprogesterone, androstenedione and testosterone in prepubertal, pubertal and adult subjects with congenital virilizing adrenal hyperplasia as indicators of adrenal suppression.
Lee PA, Urban MD, Gutai JP, Migeon CJ.
Horm Res; 1980 Sep 09; 13(6):347-57. PubMed ID: 7196877
[Abstract] [Full Text] [Related]
9. Androgens concentrations and second-to fourth-digit ratio (2D:4D) in girls with congenital adrenal hyperplasia (21-hydroxylase deficiency).
Oswiecimska JM, Ksiazek A, Sygulla K, Pys-Spychala M, Roczniak GR, Roczniak W, Stojewska M, Ziora K.
Neuro Endocrinol Lett; 2012 Sep 09; 33(8):787-91. PubMed ID: 23391972
[Abstract] [Full Text] [Related]
10. Elevated 17-hydroxyprogesterone and testosterone in a newborn with 3-beta-hydroxysteroid dehydrogenase deficiency.
Cara JF, Moshang T, Bongiovanni AM, Marx BS.
N Engl J Med; 1985 Sep 05; 313(10):618-21. PubMed ID: 3160950
[No Abstract] [Full Text] [Related]
11. [Congenital adrenal hyperplasia due to blockade of 3-beta-hydroxysteroid dehydrogenase].
Gendrel D, Chaussain JL, Roger M, Job JC.
Arch Fr Pediatr; 1979 Sep 05; 36(7):647-55. PubMed ID: 161161
[Abstract] [Full Text] [Related]
12. Morning steroid profile in children with congenital adrenal hyperplasia under different hydrocortisone schedules.
Silva IN, Oliveira-Júnior DF, Simal CJ, Viana MB, Chagas AJ.
Indian J Pediatr; 1994 Sep 05; 61(4):341-6. PubMed ID: 8002061
[Abstract] [Full Text] [Related]
13. [Medroxyprogesterone acetate. Contributive treatment in congenital adrenal hyperplasia caused by 21-hydroxylase deficiency in children].
La Selve H, Sempé M, Morel Y, Forest MG, de Peretti E, David M.
Arch Fr Pediatr; 1985 Sep 05; 42(7):511-6. PubMed ID: 2935112
[Abstract] [Full Text] [Related]
14. Effect of the dose of oral hydrocortisone on growth rate during long-term treatment of children with salt losing congenital adrenal hyperplasia.
Ciaccio M, Montiveros C, Rivarola MA, Belgorosky A.
Medicina (B Aires); 2002 Sep 05; 62(6):551-4. PubMed ID: 12532689
[Abstract] [Full Text] [Related]
15. 17-hydroxyprogesterone, androstenedione, and testosterone in normal children and in prepubertal patients with congenital adrenal hyperplasia.
von Schnakenburg K, Bidlingmaier F, Knorr D.
Eur J Pediatr; 1980 May 05; 133(3):259-67. PubMed ID: 7389739
[Abstract] [Full Text] [Related]
16. [Determination of 17-hydroxyprogesterone levels in the treatment of children with the adrenogenital syndrome].
Vavrinec J, Dvorák P, Zizkovský V, Kopecký A, Pospísilová D, Starý J.
Cesk Pediatr; 1983 Sep 05; 38(9):533-6. PubMed ID: 6315246
[No Abstract] [Full Text] [Related]
17. [Congenital virilizing adrenal hyperplasia due to 11 beta-hydroxylase deficiency. Study of eleven cases (author's transl)].
Dunand A, Roger M, Chaussain JL, Nocton F, Job JC.
Sem Hop; 1983 Sep 05; 57(33-36):1392-7. PubMed ID: 6270798
[Abstract] [Full Text] [Related]
18. Alternate day prednisone therapy in congenital adrenal hyperplasia: adrenal androgen suppression and normal growth.
Linder B, Feuillan P, Chrousos GP.
J Clin Endocrinol Metab; 1989 Jul 05; 69(1):191-5. PubMed ID: 2543690
[Abstract] [Full Text] [Related]
19. Serum cortisol and 17-hydroxyprogesterone interrelation in classic 21-hydroxylase deficiency: is current replacement therapy satisfactory?
Charmandari E, Matthews DR, Johnston A, Brook CG, Hindmarsh PC.
J Clin Endocrinol Metab; 2001 Oct 05; 86(10):4679-85. PubMed ID: 11600525
[Abstract] [Full Text] [Related]
20. [Radioimmunoassay of salivary l7 alpha-hydroxyprogesterone. Values obtained in healthy subjects and in patients treated for congenital hyperplasia of the adrenal glands].
Guechot J, Fiet J, Gourmelen M, Pham-Huu-Trung MT, Raux-Eurin MC, Brerault JL, Gueux B, Villette JM.
Ann Biol Clin (Paris); 1985 Oct 05; 43(4):333-7. PubMed ID: 4091295
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
